Searchable abstracts of presentations at key conferences in endocrinology

ea0063p884 | Diabetes, Obesity and Metabolism 3 | ECE2019

Development of diabetes after pancreatic resection

Montoro Jose Ignacio Martinez , Vega Maria Molina , Perez Ana Maria Gomez , Cea Yolanda Eslava , Almeida Jose Manuel Garcia , Munoz Miguel Angel Suarez , Madueno Francisco Jose Tinahones

Introduction: The development of diabetes is common after pancreatic surgery, so a close follow-up is essential in order to make an early diagnosis and start treatment as soon as possible.Material and methods: Data from 56 patients subjected to pancreatic surgery between 2013 and 2018 are presented. Demographic and clinical-analytical characteristics are also described. We analyzed the incidence of diabetes during the follow-up (one month after surgery [...

ea0049ep9 | Adrenal cortex (to include Cushing's) | ECE2017

Severe hypertriglyceridemia in relation to toxic levels of mitotane in a patient with stage IV adrenocortical carcinoma (ACC)

Larumbe Terroba , Soto Crespo , Goyogana Anacabe , De Linares Urbon Lopez , Sesmero Amon , Vina Ventosa , Olmedo Cuellar , Garcia Marcos , Roussel Otero , Munoz Almendros

Introduction: The use of mitotane as ACC therapy is associated with multiple adverse effects including hypercholesterolemia due to increased levels of LDL cholesterol. There are no reported cases of severe hypertriglyceridemia (HTG).Clinical case: A 59-year-old male with a personal history of dyslipidemia phenotype IV and pulmonary emphysema, former smoker and drinker was diagnosed with non-functioning left-sided ACC. Left adrenalectomy + left nephrectom...

ea0049ep180 | Endocrine tumours and neoplasia | ECE2017

Survival analysis of patients with gastroenteropancreatic neuroendocrine tumors

Sampedro-Nunez Miguel , Maillo-Nieto Angeles , Ramos-Levi Ana Maria , Huguet Isabel , Campos Sandra , Fernandez Elena , Aguirre Nerea , Munoz de Nova Jose Luis , Martin Elena , Marazuela Monica

Introduction: One of the main difficulties in the study of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) is their wide heterogeneity and variable outcome. Several potential influencing factors on patient survival have been recently identified. These factors could help predict patients’ prognosis.Objectives: Analysis of long-term survival of our GEP-NETs cohort according to the presence of metastatic disease, tumor grade, age, sex, tumor fu...

ea0049ep614 | Diabetes therapy | ECE2017

New long-acting insulins in type 1 diabetes: implications for real clinical practice

Damas-Fuentes Miguel , Diaz-Perdigones Cristina , Munoz-Garach Araceli , Molina-Vega Maria , Hernandez-Garcia Carmen , Cornejo-Pareja Isabel , Mancha-Doblas Isabel , Tinahones-Madueno Francisco J

The emergence of a new generation of long-acting insulin analogues (insulin degludec -ID- and insulin glargine 300 U/ml -IG300-) has increased treatment options in type 1 diabetes (T1D), demonstrating in clinical trials better metabolic control with lower hypoglycemia rates.Objectives: To assess characteristics of T1D patients who were given ID and IG300 in clinical practice and to evaluate their effect on metabolic control, weight, insulin dose and hypo...

ea0049ep941 | Pituitary - Clinical | ECE2017

Presurgical medical treatment in Cushing’s disease

Moreno-Moreno Paloma , Barrera-Martin Ana , Ibanez-Costa Alejandro , Alhambra-Exposito Maria Rosa , Munoz-Jimenez Concepcion , Galvez-Moreno Maria Angeles , Castano-Fuentes Justo P , Luque-Huertas Raul M

Introduction: The duration of hypercortisolism in Cushing’s disease (CD) appears to be inversely related to the reversibility of complications, which in turn increase mortality. This makes it necessary to identify medical therapies capable of normalizing cortisol overproduction before transsphenoidal surgery. The aim of this study was to determine if the clinical data of patients with CD before surgery allow predicting the presence and/or abundance of somatostatin (ssts) ...

ea0049ep1462 | Thyroid (non-cancer) | ECE2017

Prevalence of thyroid cancer in malaga and province

Hernandez-Garcia Carmen , Munoz-Garach Araceli , Doulatram Viyu , Perez-Villa Lidia , Mellado-Soria J , Robles-Cabeza L , Gonzalez-Hermoso C , Tinahones-Madueno Francisco

Introduction: Thyroid cancer is the most common endocrine neoplasia, being its papirally version the most frequent. (90% of all differentiated thyroid neoplasms). It is usually multifocal and metastasizes normally to regional lymph nodes.Objectives: To describe the prevalence of thyroid cancer and its histopathological variants in the different regions of the province of Malaga.Material and methods: We performed a retrospective des...

ea0041gp46 | Bone & Calcium Homeostasis (1) | ECE2016

Denosumab increases bone mineral density in primary hyperparathyroidism treated with cinacalcet

Munoz Jimenez Concepcion , Manuel Quesada Gomez Jose , Moreno Moreno, Maria Rosa Alhambra Exposito Paloma , Inmaculada Prior Sanchez Maria , Angeles Galvez Moreno Maria

Cinacalcet decreases and normalizes serum calcium levels across a broad severity range of primary hyperparathyroidism (PHPT), slightly reduces parathyroid hormone levels which generally remains elevated, whereas it has no effect on bone mineral density (BMD). Therefore, when administering cinacalcet to a patient with PHPT, concomitant treatment with an anti-catabolic drug should be considered.An open-labeled, prospective trial was conducted in 32 patient...

ea0041ep40 | Adrenal cortex (to include Cushing's) | ECE2016

Analysis of 176 cases of adrenal incidentaloma investigated in a single clinical center, what are we doing?

Jimenez Maria Maiz , Gutierrez Maria Calatayud , Bracamonte Milagros Sierra , Librizzi Soledad , Nino Virginia Rodriguez , Munoz Myriam Lorena Partida , Carranza Federico Hawkins

Introduction: Patients referred for adrenal incidentalomas (AI) are increasing. Current guidelines are controversial on diagnosis and length of follow-up.Objectives: Analyze clinical, radiologic and hormonal characteristics of patients with AI. Evaluate the number and usefulness of tests needed for diagnosis, clinical outcome and follow up.Material and methods: Observational, retrospective study in patients with AI in our endocrino...

ea0041ep1139 | Thyroid cancer | ECE2016

Our experience with low doses of radioactive iodine (30 mCi) in patients with differentiated thyroid cancer

Prior-Sanchez Inmaculada , Munoz Jimenez Concepcion , Moreno Moreno Paloma , Rebollo Roman Angel , Barrera Martin Ana , Moreno Ortega Estefania , Antonio Vallejo Casas Juan , Angeles Galvez Moreno Maria

Background: The management of patients with differentiated thyroid cancer (DTC) has been changing in recent years and aggressiveness of treatment depends on the risk of persistent or recurrent disease.Objective: The aim of this study was to assess the efficacy of low doses of Radioactive Iodine (RAI;131I) therapy in patients with DTC.Methods: We retrospectively evaluated all patients who were diagnosed with DTC (n</e...

ea0037gp.28.09 | Endocrine tumours and neoplasia – NETS | ECE2015

Association of angiopoietin/TIE2 plasma level and VEGF system with progression in gastroenteropancreatic neuroendocrine tumors

Sampedro-Nunez Miguel , Ramos-Levi Ana , Vicuna Alicia , Campos Sandra , Serrano Ana , Rodriguez-Munoz Ana , Martinez-Hernandez Rebeca , Martin-Perez Elena , Adrados Magdalena , Marazuela Monica

Introduction: Angiopoietins (ANG) -1 and 2, their receptor TIE2, and the vascular endothelial growth factor (VEGF) are involved in the process of angiogenesis. However, their role in the pathogenesis and development of gastroenteropancreatic neuroendocrine tumours (GEP-NETs) is not completely understood. In a previous study of 42 patients with GEP-NET, we observed an elevation of these serum markers, especially in those with metastatic disease. The objective of this study was ...